Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-11-17 07:00:00
Oslo, Norway - 17 November 2022 - Circa Group AS (Euronext Growth Oslo: CIRCA)
today announced its third quarter results. A webinar will be held at 08.30 CET
(details below).
An important milestone has been met with Circa and Valmet signing a contract for
the supply of core equipment to the ReSoluteTM plant, as announced in early
November. Contracts with other major vendors are progressing as planned and work
is moving towards final contract stages. Cost mitigation measures continue to
combat sustained inflationary pressures.
"During Q3 we have taken significant steps closer to the commissioning of
ReSoluteTM at the end of 2023, and our future plans for the next plant are taking
shape, with Circa and Valmet signing a conceptual engineering agreement for FC6
(next stage >10 000 tonne plant). The Circa Renewable Chemistry Institute is
actively working with customers on the use of CyreneTM in industrial processes,
and the sharing of our expertise has been well received. The appointment of Nick
Smith as head of development and commercialisation places Circa in a strong
position to advance new products and secure commitments for CyreneTM volumes from
distributors, partners and customers" says CEO Tony Duncan.
Commercial interest in CyreneTM continues to develop with negotiations
progressing in key markets. Circa provides a safer low carbon alternative to
toxic fossil-based chemicals, including the bio-solvent CyreneTM, which will be
manufactured at ReSoluteTM. With 1,000 tonnes production capacity it is the first
industrial scale plants that will be commissioned in a growth plan that will see
capacity increase to 80,000 tonnes per year by 2030.
The company remains well-funded following the EUR 50 million capital raising in
March 2021, further supported by grants from the EU and French Government. No
significant sales are expected prior to commissioning and start-up of the
ReSoluteTM plant. Projections indicate a satisfactory financial runway.
To access the complete Q3 report:
https://circa-group.com/investors/reports-presentations/
To join the Q3 results webinar please copy and paste this link into your web
browser:
https://teams.microsoft.com/l/meetup-join/19%3ameeting_NGVkMDdlNzUtZmFmOS00NDJmL
TgwZWYtZjU2ZDM0N2E2ZjRk%40thread.v2/0?context=%7b%22Tid%22%3a%227fe83212-6533-49
bf-96c7-1c50525cb252%22%2c%22Oid%22%3a%22b5d8e996-8850-4133-9fce-bf140a9a7209%22
%7d
About Circa
Established in 2006, Circa Group converts non-food biomass into advanced
bio-based chemicals with its proprietary FuracellTM process. Its developing
product portfolio includes flavours, biopolymers, and bio-solvents including
CyreneTM. Circa's ReSoluteTM plant will produce green and sustainable solvents at
industrial scale by utilising local certified forest biomass, replace
conventional harmful solvents traditionally made from petrochemicals. The plant
will be the first of its kind to produce the bio-solvent CyreneTM at scale. By
creating renewable chemicals from cellulose, Circa is extracting value from
non-food, surplus biomass and contributing to industry as it transitions to a
more circular and decarbonised economy. Circa Group is listed on the Euronext
Growth Market in Oslo, stock symbol CIRCA.
www.circa-group.com
Investor Contact Circa Group
Tone Leivestad, Chief Financial Officer
Circa Group AS
tone.leivestad@circa-group.com
Tel: +47 406 39 455
Media Contact
Amanda Keogh
General Manager Marketing and Sustainability
Circa Group AS
Amanda.keogh@circa-group.com
Tel: +61 407 275 126